References
- Proietti M, Lip GYH, Laroche C, et al. Relation of outcomes to ABC (atrial fibrillation better care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. Europace. 2021;23(2):174–183.
- Evans W, Swann P. Lone auricular fibrillation. Br Heart J. 1954;16(2):189–194.
- Boriani G, Vitolo M, Diemberger I, et al. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res. 2021;117(7):1–21.
- Imberti JF, Bonini N, Tosetti A, et al. Atrial high-rate episodes detected by cardiac implantable electronic devices: dynamic changes in episodes and predictors of incident atrial fibrillation. Biology. 2022;11(3):443.
- Malavasi VL, Fantecchi E, Tordoni V, et al. Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med. 2021;16(5):1131–1140.
- Boriani G, Vitolo M, Imberti JF, et al. What do we do about atrial high rate episodes? Eur Heart J Suppl. 2020;22(O):O42–O52.
- Albini A, Malavasi VL, Vitolo M, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med. 2021;85:27–33.
- Lubitz SA, Yin X, Rienstra M, et al. Long-term outcomes of secondary atrial fibrillation in the community: the framingham heart study. Circulation. 2015;131(19):1648–1655.
- Maisano A, Vitolo M, Imberti J, et al. Atrial fibrillation in the setting of acute pneumonia: not a secondary arrhythmia. Rev Cardiovasc Med. 2022;23(5):176–114.
- Sardana M, Hsue PY, Tseng ZH, et al. Human immunodeficiency virus infection and incident atrial fibrillation. J Am Coll Cardiol. 2019;74(11):1512–1514.
- Hsu JC, Li Y, Marcus GM, et al. Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. J Am Coll Cardiol. 2013;61(22):2288–2295.
- Antwi-Amoabeng D, Ghuman J, Sathappan S, et al. Influence of HIV on in-hospital outcomes in patients with atrial fibrillation. Acta Cardiol. 2022;1–8. DOI:10.1080/00015385.2022.2129185
- Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492–500.
- Imberti JF, Mei DA, Vitolo M, et al. Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med. 2022;101:1–7.
- Guo Y, Imberti JF, Kotalczyk A, et al. 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients. Eur J Clin Invest. 2022;52(6):e13751.
- Vitolo M, Proietti M, Malavasi VL, et al. Adherence to the “atrial fibrillation better care” (ABC) pathway in patients with atrial fibrillation and cancer: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation (EORP-AF) General Long-Term Registry. Eur J Intern Med. 2022;105:54–62.
- Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–1316.
- Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107(20):1630–1636.